Research and Markets: Analysis of Molecular Diagnostics Technologies And Strategic Profiles of Leading Suppliers such as Abbott, Novartis and Roche

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of the "Analysis of Molecular Diagnostics Technologies And Strategic Profiles of Leading Suppliers" report to their offering.

This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

The report also presents strategic assessments of current and emerging suppliers of molecular diagnostics products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Key Topics Covered:

DNA Sequencing

DNA And RNA Probe Technology

Detection Technologies

Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

Competitive Profiles

Competitive Profiles

- Abbott

- Affymetrix

- Agilent

- Applied Gene Technologies

- Arca

- Beckman Coulter/Danaher

- Becton Dickinson

- Biokit

- BioMerieux

- Bio-Rad

- Biotest

- Caliper

- Cepheid

- Decode

- Diadexus

- Eiken

- Enzo

- Exact Sciences

- Fujirebio

- Gen-Probe

- Hologic

- Illumina

- Innogenetics/Solvay

- Kreatech

- Li-Cor Biosciences

- Life Technologies

- Monogram Biosciences

- Myriad Genetics

- Nanogen/Elitech

- Novartis

- Orchid CellMark

- Ortho-Clinical Diagnostics

- Proteome Sciences

- Qiagen

- Roche

- Scienion

- Sequenom

- Shimadzu

- Siemens

- Sierra Molecular

- Takara Bio

- Tecan Group

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Source: Research and Markets